Facebook Instagram Linkedin Youtube

Donate

Facebook Instagram Linkedin Youtube

2025 Funded Projects

• Targeting an Oncogenic Driver in Infant Acute Lymphoblastic Leukemia: Bedside to Bench Correlative Studies

  Kelly Faulk, Patricia Ernst | Children’s Hospital Colorado and University of Colorado Anschutz Medical Campus

• A de novo map of the medulloblastoma transcriptome

  John Prensner | University of Michigan Medical School

• Translating discoveries from brain tumor genomics into new therapeutic strategies

  David Solomon | Lucille Packard Children’s Hospital Stanford University

• Cell free tumor DNA burden, cell free tumor DNA Myc signature, and circulating tumor cell pharmacodynamics

  Brian Crompton | Dana-Farber Cancer Institute

• Identification of the chromosome 1q oncogenic driver gene in posterior fossa ependymoma using functional genomic screening

  Nicholas Foreman | Children’s Hospital Colorado and University of Colorado Anschutz Medical Campus

• Remodeling the immunosuppressive tumor microenvironment in pediatric ependymoma

  Nicholas Foreman, Andrea Griesinger | Children’s Hospital Colorado and University of Colorado Anschutz Medical Campus

• Targeting cellular crosstalk mechanisms to develop novel treatment strategies for NF1-associated plexiform neurofibromas

  Nicholas Foreman | Children’s Hospital Colorado and University of Colorado Anschutz Medical Campus

• Omics “in the round”

  Nicholas Foreman | Children’s Hospital Colorado and University of Colorado Anschutz Medical Campus

• BioInformatics support from Pluto

  Rajeev Vibhakar | Children’s Hospital Colorado and University of Colorado Anschutz Medical Campus

• Improving B7H3 CAR-T efficacy in medulloblastoma

  Dong Wang, Rajeev Vibhakar | Children’s Hospital Colorado and University of Colorado Anschutz Medical Campus

• Evaluation of KDM4B

  Bethany Veo, Rajeev Vibhakar | Children’s Hospital Colorado and University of Colorado Anschutz Medical Campus

• Establish the efficacy of IDH1 inhibition in Myc amplified radiation resistant in vivo models

  Bethany Veo, Rajeev Vibhakar | Children’s Hospital Colorado and University of Colorado Anschutz Medical Campus

• Single cell Resolution of ATRT

  Irina Alimova, Bethany Veo, Nathan Dahl, Rajeev Vibhakar | Children’s Hospital Colorado and University of Colorado Anschutz Medical Campus

• Re-purposing an FDA-approved anti-malarial drug to treat DIPG, a fatal brain tumor in children

  Sujatha Venkataraman, Rajeev Vibhakar | Children’s Hospital Colorado and University of Colorado Anschutz Medical Campus

• Pre-clinical testing the potential synergy between Radiotherapy and Gated CAR-T cell therapy against pediatric brain tumor

  Sujatha Venkataraman, Eric Kohler | Children’s Hospital Colorado and University of Colorado Anschutz Medical Campus

• Pre-clinical Investigation to Support IIT of CDK7 inhibition in Pediatric Embryonal CNS Tumors

  Jean Mulcahy Levy, Bethany Veo | Children’s Hospital Colorado and University of Colorado Anschutz Medical Campus

• Development of a novel CDK12 protein degrader model

  Nathan Dahl | Children’s Hospital Colorado and University of Colorado Anschutz Medical Campus

• Targeting CDK11 in High Risk Neuroblastoma

  Raymond Walston, Nathan Dahl | Children’s Hospital Colorado and University of Colorado Anschutz Medical Campus

• Combining Cellular Immunotherapy and Chemotherapy for the Treatment of Canine and Pediatric High-Grade Gliomas using Laboratory Comparative Oncology Techniques and a Canine Clinical Trial

  Adam Green, Mike Verneris, Steven Dow | Children’s Hospital Colorado and University of Colorado Anschutz Medical Campus

• Investigation of Immunotherapy Approaches for Cancer Prevention

  Adam Green | Children’s Hospital Colorado and University of Colorado Anschutz Medical Campus

• Investigation of tumor architecture and microenvironment evolution during relapse of pediatric brain tumors

  Adam Green, Nichaolas Foreman | Children’s Hospital Colorado and University of Colorado Anschutz Medical Campus

• Incorporating radiotherapy and proteasome inhibition for high-risk pediatric brain tumors

  Nathan Dahl, Adam Green | Children’s Hospital Colorado and University of Colorado Anschutz Medical Campus

• Determine the clonal progression of c-Myc medulloblastoma metastasis to the spine and forebrain through DNA barcoding

  Siddhartha Mitra | Children’s Hospital Colorado and University of Colorado Anschutz Medical Campus

• Determine the unique immune microenvironment of EGFR mutant thalamic diffused midline glioma using In-Utero-Electroporation models

  Siddhartha Mitra, Santos Franco, Adam Green | Children’s Hospital Colorado and University of Colorado Anschutz Medical Campus

• Validating Eye-Tracking for AI in Pediatric Tumor Diagnosis

  Todd Hankinson, Carsten Görg | Children’s Hospital Colorado and University of Colorado Anschutz Medical Campus

• Characterizing and Cryo-Banking Adamantinomatous Craniopharyngioma Organoid Systems

  Todd Hankinson, Siddhartha Mitra | Children’s Hospital Colorado and University of Colorado Anschutz Medical Campus

• Validation of Patient Derived Xenograft Models of Adamantinomatous Craniopharyngioma

  Todd Hankinson, Siddhartha Mitra | Children’s Hospital Colorado and University of Colorado Anschutz Medical Campus

• WillStrong Fund Scholar Award

  Matthew Witkowski | Children’s Hospital Colorado and University of Colorado Anschutz Medical Campus